| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OPKO HEALTH, INC. | Executive VP-Administration, Director | Common Stock | 6.63M | $8.38M | $1.27 | Jul 24, 2024 | Direct |
| Red Violet, Inc. | Director | Common Stock | 141K | $5.49M | $38.93 | Mar 19, 2025 | Direct |
| Cocrystal Pharma, Inc. | Director | Common Stock | 2.66M | $5.24M | $1.97 | Oct 9, 2024 | Direct |
| Eloxx Pharmaceuticals, Inc. | Director | Restricted Stock Units | 3.75K | $5.4K | $0.72 | Jan 24, 2025 | Direct |
| OPKO HEALTH, INC. | Executive VP-Administration, Director | Stock Option (Right to Buy) | 438K | May 27, 2025 | Direct | ||
| Niagen Bioscience, Inc. | Director | Stock Option (right to buy) | 20K | Jun 24, 2025 | Direct | ||
| Eloxx Pharmaceuticals, Inc. | Director | Common Stock | 15.8K | Jan 24, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NAGE | Niagen Bioscience, Inc. | Jun 24, 2025 | 1 | $0 | 4 | Jun 25, 2025 | Director |
| OPK | OPKO HEALTH, INC. | May 27, 2025 | 1 | $0 | 4 | May 29, 2025 | Executive VP-Administration, Director |
| RDVT | Red Violet, Inc. | Mar 19, 2025 | 1 | -$389K | 4 | Mar 21, 2025 | Director |
| ELOX | Eloxx Pharmaceuticals, Inc. | Jan 24, 2025 | 2 | $0 | 4 | Jan 28, 2025 | Director |
| RDVT | Red Violet, Inc. | Nov 4, 2024 | 1 | $0 | 4 | Nov 5, 2024 | Director |
| ELOX | Eloxx Pharmaceuticals, Inc. | Oct 16, 2024 | 1 | $0 | 4 | Oct 17, 2024 | Director |
| COCP | Cocrystal Pharma, Inc. | Oct 9, 2024 | 1 | $0 | 4 | Oct 11, 2024 | Director |
| OPK | OPKO HEALTH, INC. | Jul 24, 2024 | 1 | $0 | 4 | Jul 26, 2024 | Executive VP-Administration, Director |
| CDXC | ChromaDex Corp. | Jun 20, 2024 | 1 | $0 | 4 | Jun 24, 2024 | Director |
| ELOX | Eloxx Pharmaceuticals, Inc. | Jan 24, 2024 | 1 | $0 | 4 | Jan 26, 2024 | Director |
| OPK | OPKO HEALTH, INC. | Jan 5, 2024 | 1 | $8.67K | 4 | Jan 5, 2024 | Executive VP-Administration, Director |
| RDVT | Red Violet, Inc. | Nov 30, 2023 | 1 | $0 | 4 | Dec 4, 2023 | Director |
| OPK | OPKO HEALTH, INC. | Nov 10, 2023 | 1 | $13K | 4 | Nov 13, 2023 | Executive VP-Administration, Director |
| COCP | Cocrystal Pharma, Inc. | Jul 18, 2023 | 1 | $0 | 4 | Jul 20, 2023 | Director |
| CDXC | ChromaDex Corp. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
| CDXC | ChromaDex Corp. | May 25, 2023 | 1 | $10.2K | 4 | May 30, 2023 | Director |
| OPK | OPKO HEALTH, INC. | May 18, 2023 | 1 | $0 | 4 | May 19, 2023 | Executive VP-Administration, Director |
| ELOX | Eloxx Pharmaceuticals, Inc. | Jan 30, 2023 | 1 | $0 | 4 | Jan 31, 2023 | Director |
| RDVT | Red Violet, Inc. | Oct 12, 2022 | 1 | $0 | 4 | Oct 13, 2022 | Director |
| COCP | Cocrystal Pharma, Inc. | Jul 25, 2022 | 1 | $0 | 4 | Aug 3, 2022 | Director |
| CDXC | ChromaDex Corp. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
| ELOX | Eloxx Pharmaceuticals, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| RDVT | Red Violet, Inc. | Sep 24, 2021 | 1 | $0 | 4 | Sep 27, 2021 | Director |
| COCP | Cocrystal Pharma, Inc. | Jul 16, 2021 | 1 | $0 | 4 | Jul 20, 2021 | Director |
| CDXC | ChromaDex Corp. | Jun 17, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |
| ELOX | Eloxx Pharmaceuticals, Inc. | May 19, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |